Rybo Dynamics is in the relentless pursuit of front-running scientific breakthroughs that give labs all over the world the ability to develop revolutionary medicines that will create a healthier world for all and healthy life for you.
Location: United States
Total raised: $14M
Investors 1
| Date | Name | Website |
| - | Phase Two ... | phasetwo.v... |
Funding Rounds 2
| Date | Series | Amount | Investors |
| 25.03.2026 | Seed | $10M | Genedant |
| 12.01.2025 | Pre-Seed | $4M | - |
Mentions in press and media 9
| Date | Title | Description |
| 27.03.2026 | RyboDyn Secures $10M Seed Funding for AI-Powered Cancer Target Discovery | Biotech firm RyboDyn landed $10 million in seed funding. The San Diego company pioneers an AI-driven platform. It decodes the "dark proteome." This unlocks hidden cancer targets. Traditional methods miss these crucial markers. The... |
| 25.03.2026 | RyboDyn: $10 Million Seed Funding Raised For AI-Powered Cancer Target Discovery | RyboDyn, a biotechnology company focused on decoding the dark proteome to uncover new cancer targets, announced the initial close of a $10 million seed financing round. The company said the funding will support its transition from foundatio... |
| 24.03.2026 | RyboDyn Raises $10M in Seed Funding | RyboDyn, Inc., a San Diego, CA-based biotechnology company providing an AI-powered sequencing and discovery platform, raised $10M in Seed funding. Backers were not disclosed. The company intends to use the funds to expand operations and its... |
| 11.08.2025 | SeaX: Interview With Founder & CEO Kid Parchariyanon About The Early-Stage Investment Firm | Southeast Asia Exponential Ventures (SeaX) is a VC fund investing globally in early-stage companies with game-changing “exponential” technologies. Pulse 2.0 interviewed SeaX founder and CEO Kid Parchariyanon to gain a deeper understanding o... |
| 14.01.2025 | RyboDyn: Unveiling the Dark Genome with $4 Million in Pre-Seed Funding | In the world of biotechnology, innovation is the lifeblood. RyboDyn, a San Diego-based company, has just taken a bold step forward. With $4 million in pre-seed funding, they aim to illuminate the dark corners of the human genome. This fundi... |
| 12.01.2025 | RyboDyn: $4 Million (Pre-Seed) Raised To Pioneer Development Of First-In-Class Immunotherapies | RyboDyn announced the discovery of a new proteome and the successful closing of a $4 million pre-seed financing round to advance its mission of targeting the dark proteome to develop novel immunotherapies. The funding round was co-led by Ge... |
| 09.01.2025 | RyboDyn Raises $4M in Pre-Seed Funding | RyboDyn, a San Diego, CA-based biotechnology company developing immunotherapies targeting the dark genome, raised $4M in Pre-Seed funding. The round was led by Genedant Capital and SeaX Ventures, with participation from SOSV and Swell VC. T... |
| - | Rybodyn | “Rybodyn unlocks the dark proteome to develop first-in-class immunotherapies with AI and high-resolution RNA sequencing via its RyboCypher™ platform.” |
| - | Rybodyn | “Rybo Dynamics is in the relentless pursuit of front-running scientific breakthroughs that give labs all over the world the ability to develop revolutionary medicines that will create a healthier world for all and healthy life for you. ”... |